These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 17633094)
1. [Current status and future perspectives of the Glivec Registration System established by JSCH/JSH-TARGET]. Kizaki M; Rinsho Ketsueki; 2007 Jun; 48(6):468-74. PubMed ID: 17633094 [No Abstract] [Full Text] [Related]
2. Chronic phase of ETV6-ABL1 positive CML responds to imatinib. Kawamata N; Dashti A; Lu D; Miller B; Koeffler HP; Schreck R; Moore S; Ogawa S Genes Chromosomes Cancer; 2008 Oct; 47(10):919-21. PubMed ID: 18615681 [No Abstract] [Full Text] [Related]
15. Current and future perspectives on the TARGET system: the registration system for Glivec established by the JSH. Kizaki M; Okamoto S; Tauchi T; Tanaka H; Tanimoto M; Inokuchi K; Murayama T; Saburi Y; Hino M; Tsudo M; Shimomura T; Isobe Y; Int J Hematol; 2008 Nov; 88(4):409-417. PubMed ID: 18953513 [TBL] [Abstract][Full Text] [Related]
16. Imatinib resistance in CML. Volpe G; Panuzzo C; Ulisciani S; Cilloni D Cancer Lett; 2009 Feb; 274(1):1-9. PubMed ID: 18653275 [TBL] [Abstract][Full Text] [Related]
17. Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy. Jilani I; Kantarjian H; Gorre M; Cortes J; Ottmann O; Bhalla K; Giles FJ; Albitar M Leuk Res; 2008 Apr; 32(4):643-9. PubMed ID: 17900686 [TBL] [Abstract][Full Text] [Related]
18. Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML). Tsapas A; Vlachaki E; Sarigianni M; Klonizakis F; Paletas K Leuk Res; 2008 Apr; 32(4):674-5. PubMed ID: 17920117 [No Abstract] [Full Text] [Related]
19. Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis. Radojkovic M; Ristic S; Pavlovic S; Colovic M Leuk Res; 2009 Jun; 33(6):e10-2. PubMed ID: 19091403 [TBL] [Abstract][Full Text] [Related]
20. Regression of cutaneous squamous cell carcinoma in a patient with chronic myeloid leukaemia on imatinib mesylate treatment. Kawakami Y; Nakamura K; Nishibu A; Yanagihori H; Kimura H; Yamamoto T Acta Derm Venereol; 2008; 88(2):185-6. PubMed ID: 18311459 [No Abstract] [Full Text] [Related] [Next] [New Search]